SS Innovations International, Inc, a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has announced that the company has unveiled its vision for several cutting-edge surgical robotic technologies at the Global Multi-Specialty Robotic Surgery Conference – SMRSC 2026, which the company recently hosted in New Delhi, India.
Key innovations under development by the company and showcased at SMRSC 2026 include the SSi Vimana Aero Drone System, the SSi Avtara Humanoid Surgical Platform, the SSi Operion Mobile Operating Room, and new single-arm robotic endoscopy and ultrasound assist carts.
The SSi Vimana Aero is a surgical robotic system currently under development and designed to bring expert robotic surgical care directly to wounded soldiers in active battle zones, bridging the critical time gap between initial point of injury and eventual medical evacuation from the frontlines.
Deployed via a heavy-lift autonomous drone, the SSi Vimana Aero can land in proximity to the casualty and deploy two miniature robotic arms with seven degrees of freedom. A trauma surgeon then can remotely operate the SSi Vimana Aero, which is equipped with 5-millimeter surgical instruments, through an SSi Mantra surgeon command centre.
The SSi Vimana Aero is a surgical robotic system currently under development and designed to bring expert robotic surgical care directly to wounded soldiers in active battle zones, bridging the critical time gap between initial point of injury and eventual medical evacuation from the frontlines
The SSi Vimana Aero platform is intended to address haemorrhaging, wound repair, chest decompression, shrapnel extraction, and field suturing, among other procedures, to help stabilise patients until evacuation teams arrive.
The SSi Avtara, another innovation under conceptual development, aims to leverage the advanced mobility, dexterity, and perception capabilities of humanoid systems for high-impact surgical robotic applications spanning healthcare, defence, logistics, disaster response, and industrial settings.
Integrated with artificial intelligence, teleoperation frameworks, and real-time sensing, the SSi Avtara will be designed for trainability, continuous learning, adaptability, and precision in the field. From assisting clinical workflows to operating in hazardous or otherwise inaccessible environments, the company anticipates that the platform’s human-compatible design will enable seamless interaction with existing infrastructure and tools.
The SSi Operion, also currently under development, is a fully mobile, platform-agnostic operating room ecosystem designed for seamless deployment across hospitals, remote locations, combat areas, and disaster zones.
The SSi Operion is designed to be built on a wheeled chassis with overhead-integrated robotics and a zero-footprint architecture, which seeks to eliminate conventional spatial constraints by suspending all surgical components from an integrated overhead system, enabling 360-degree clinician access, real-time reconfiguration, and seamless deployment.
With integrated telesurgery capabilities and low-latency connectivity, the SSi Operion is expected to enable expert surgeons to operate remotely, expanding access to advanced surgical care across geographies.
The SSi Vimana Aero platform is intended to address haemorrhaging, wound repair, chest decompression, shrapnel extraction, and field suturing, among other procedures, to help stabilise patients until evacuation teams arrive
From defence operations to humanitarian missions and rural healthcare delivery, SS Innovations believes that SSi Operion holds potential to transform the operating room into a deployable, mission-ready asset.
The company’s new single-arm robotic endoscopy and ultrasound assist carts, currently proceeding through early clinical validation phases in India, are designed to provide stable, precise, and repeatable positioning of endoscopic and ultrasound instruments within clinical environments, bringing robotic consistency to workflows.
Operating under direct clinician supervision, the robotic arms incorporate controlled speed, force limits, and predictable motion behaviour, ensuring safe interaction with both patients and operators. Compatibility with standard hospital infrastructure and existing clinical workflows allows for seamless integration into established clinical settings.
Integrated with artificial intelligence, teleoperation frameworks, and real-time sensing, the SSi Avtara will be designed for trainability, continuous learning, adaptability, and precision in the field. From assisting clinical workflows to operating in hazardous or otherwise inaccessible environments, the company anticipates that the platform’s human-compatible design will enable seamless interaction with existing infrastructure and tools
Dr Sudhir Srivastava, Chairman and Chief Executive Officer of SS Innovations, commented, “Innovation is in our DNA. Beyond continuously improving our advanced, cost-effective SSi Mantra surgical robotic system and telesurgery capabilities, we strive to pioneer new surgical robotic technologies that will meaningfully improve healthcare for a wider segment of patients in need. SMRSC 2026, our largest conference yet, successfully elevated this important theme.”
SMRSC 2026 brought together distinguished surgeons, global thought leaders, educators, and prominent healthcare innovators to discuss and shape the future of robotic surgery.
Attendance at SMRSC 2026 surpassed that of last year’s conference, drawing more than 1,600 attendees and 1,800 virtual participants from 19 nations. In addition to unveiling new surgical robotic technologies and groundbreaking concepts at SMRSC 2026, SS Innovations showcased the SSi Mantra’s capabilities.
At the conference, expert physicians conducted 10 live telesurgeries and 13 live robotic surgeries across multiple specialties utilising the SSi Mantra.
The three-day event also featured dozens of panel discussions spanning specialties, including urology, thoracic, gastroenterology, head & neck, gynaecology, colorectal, general and paediatric, among others, with separate cardiac-focused breakout sessions.
An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions
Prominent guests and presenters at this year’s conference included, among others, the Company’s Vice-Chairman, Dr Fred Moll, who has been widely recognised as the “Father of Robotic Surgery”; Pratap Rao Jadhav, the Minister of State for Health and Family Welfare of India; Sri Madhusudan Sai, a global humanitarian and founder of a worldwide free healthcare mission; and Dr Mylswamy Annadurai, Former Director, ISRO Satellite Center.
SS Innovations International, Inc develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.
An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
